- Research works
- 27 ▼ 73% vs 2013–17
- Citations
- 202 7.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Biocartis (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Biocartis (Belgium)?
By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cancer Genomics, Mutational Signatures, Molecular Characterization, Hereditary Syndromes, Microsatellite Instability, Immune Response and Precision Medicine.
- Convolutional Neural Networks
- Real-Time PCR
- Machine Learning
- COVID-19
- Data Analysis
- EGFR Mutations
- Medical Imaging
- Vaccine
- KRAS Mutations
- Deep Learning
- Antiretroviral Therapy
- Immune Response
- Hereditary Syndromes
- Epidemiology
- Cancer Genomics
- Targeted Therapy
- Mutational Signatures
- Molecular Characterization
- Microsatellite Instability
- Precision Medicine
- Chemotherapy
- Cetuximab
- Vaccine Development
- Clinical Trials
- ALK Inhibitors
- Gene Expression
- Normalization
- Immunotherapy
- Quantitative
- Chest X-Ray
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Targeted Therapy5▲ 82×2 topics
- Cancer Genomics3▲ 234×1 topic
- Mutational Signatures3▲ 234×1 topic
- Epidemiology3▲ 2.9×14 topics
- Molecular Characterization3▲ 59×2 topics
- Hereditary Syndromes3▲ 271×1 topic
- Microsatellite Instability3▲ 271×1 topic
- Immune Response2▲ 13×6 topics
- Precision Medicine2▲ 25×2 topics
- Antiretroviral Therapy2▲ 30×3 topics
- Chemotherapy2▲ 9.7×2 topics
- Deep Learning2▲ 3.1×3 topics
- Cetuximab2▲ 76×1 topic
- KRAS Mutations2▲ 188×1 topic
- Vaccine Development2▲ 20×4 topics
- Vaccine2▲ 14×5 topics
- Clinical Trials1▲ 8.3×3 topics
- Medical Imaging1▲ 19×2 topics
- ALK Inhibitors1▲ 88×1 topic
- EGFR Mutations1▲ 88×1 topic
- Gene Expression1▲ 8.1×3 topics
- Data Analysis1▲ 14×2 topics
- Normalization1▲ 62×2 topics
- COVID-191▲ 6.4×2 topics
- Immunotherapy1▲ 6.5×6 topics
- Machine Learning1▲ 1.97×3 topics
- Quantitative1▲ 34×1 topic
- Real-Time PCR1▲ 94×1 topic
- Chest X-Ray1▲ 149×1 topic
- Convolutional Neural Networks1▲ 8.9×1 topic
Which research topics does Biocartis (Belgium) publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, Advanced Biosensing Techniques and Applications, Cell Image Analysis Techniques and Molecular Biology Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 2 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
- 3 Cell Image Analysis Techniques Biophysics 0 works
- 4 Molecular Biology Techniques and Applications Molecular Biology 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 7 Bacterial Infections and Vaccines Microbiology 0 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 9 CAR-T cell therapy research Oncology 0 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biocartis (Belgium)'s research output changed?
Output in 2018–2022 was 73% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mechelen
- Rode Kruis-Vlaanderen
- Galapagos (Belgium)
- Technopolis
- De Lijn (Belgium)
- Cypress Semiconductor Corporation (Belgium)
- Public Waste Agency of Flanders
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.